David Palling - Sr VP, Amicus Therapeutics Inc
As of June 30, 2009
David Palling Net Worth
- Net worth is estimated to be at least $1.02M
- Owns at least 34,040 units of Amicus Therapeutics Inc stock
- Sold an estimated value of $450.86K in the last year at Amicus Therapeutics Inc
David Palling Trading
- Largest sale of shares was 9,998 units , worth over $101.33K on June 30, 2009
- In total has made about 17 transactions over a year
- Usually trades in March, with the busiest year in 2008
David Palling
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
David Palling Mailing Address
- Mailing address is C/o Amicus Therapeutics, Inc. 6 Cedar Brook Drive Cranbury NJ 08512 NJ
Amicus Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Change in Pension Value
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|---|
John F. Crowley | 2020 | $719,514 | $514,800 | $5,479,971 | $2,492,491 | $1,282,843 | $825,505 | $11,315,124 |
John F. Crowley | 2019 | $656,770 | $476,815 | $5,327,948 | $2,334,850 | $234,775 | $821,505 | $9,852,663 |
John F. Crowley | 2018 | $637,640 | $445,710 | $3,861,699 | $1,654,347 | - | $820,567 | $7,419,963 |
Daphne Quimi | 2020 | $45 | $228,712 | $1,534,382 | $697,894 | - | $34,639 | $2,947, |
Daphne Quimi | 2019 | $400,000 | $212,960 | $1,311,492 | $538,808 | - | $17,487 | $2,480,747 |
Daphne Quimi | 2018 | - | - | - | - | - | - | - |
Bradley L. Campbell | 2020 | $515, | $368,872 | $2,557,304 | $1,163,159 | - | $33,694 | $4, |
Bradley L. Campbell | 2019 | $500,877 | $378,788 | $2,254,114 | $987,822 | - | $19,538 | $4,141,139 |
Bradley L. Campbell | 2018 | $468,109 | $327,209 | $1,411,802 | $604,817 | - | $16,710 | $2,828,646 |
Hung Do | 2020 | $42 | $187,908 | $1,461,322 | $664,660 | - | $31,248 | $2,772,106 |
Hung Do | 2019 | $414,625 | $200,678 | $1,393,462 | $574,732 | - | $22,129 | $2,605,626 |
Hung Do | 2018 | - | - | - | - | - | - | - |
Ellen S. Rosenberg | 2020 | $452, | $199,051 | $1,461,322 | $664,660 | $87,751 | $20,748 | $2,885,820 |
Ellen S. Rosenberg | 2019 | $439,213 | $233,837 | $1,393,462 | $610,648 | - | $13,538 | $2,690,698 |
Ellen S. Rosenberg | 2018 | $426,420 | $208,647 | $996,591 | $426,933 | - | $18,270 | $2,076,862 |
Jay Barth | 2020 | $366,269 | - | $1,315,184 | $598,197 | - | $641,306 | $2,920,956 |
Jay Barth | 2019 | $471,621 | $228,265 | $1,229,522 | $538,808 | - | $15,998 | $2,484,214 |
Jay Barth | 2018 | $457,885 | $192,037 | $996,591 | $426,933 | - | $18,790 | $2,092,236 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1178879/000114036121014545/nc10021408x1_def14a.htm
Amicus Therapeutics Inc Insider Trading
- The most recent transaction was 15,000 units sold on May 4, 2022 by Margaret McGlynn worth over $104.9K
- In the last 15 years, insiders at Amicus Therapeutics Inc sold an estimated value of $173.38M and bought an estimated value of $191.98M
- The most active traders are John Crowley, Chairman & CEO, Bradley Campbell, Chief Operating Officer, and James N Topper, Director
- Insider trading is most common in June, with the busiest year in 2008
AMICUS THERAPEUTICS, INC. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |